.On the heels of an FDA denial for its chief rival Novo Nordisk, Eli Lilly is pushing on in the nati...
.Simply a handful of months after application the very first person in a phase 2 trial for newly dia...
.Eli Lilly's hunt for obesity targets has actually led it to the black genome. The Big Pharma has as...
.Toolbox Biosciences is going on up. The tissue treatment business has actually added on $325 thousa...
.After raising $170 million back in February, metabolic disease-focused BioAge Labs has filed to deb...
.Aelis Farma's hopes of protecting a quick, favorable selection on a $100 million option remittance ...
.ProKidney has actually stopped among a pair of period 3 trials for its tissue therapy for renal hea...
.Vaxcyte introduced what analysts called "stunning" phase 1/2 data for its own 31-valent pneumococca...
.Recursion has stumbled with a very early examination of its own tech-enabled approach to drug explo...
.Phone it a case of great chemistry: Acepodia, a biotech based upon Nobel Prize-winning scientific r...